Peer Review History

Original SubmissionOctober 22, 2019
Decision Letter - Wen-Jun Tu, Editor

PONE-D-19-29504

Knowledge and attitudes regarding diabetic retinopathy among diabetic patients registered in a chronic disease management system in eastern China

PLOS ONE

Dear Mr. Chen,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by May 31 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Wen-Jun Tu

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Acknowledgments Section of your manuscript:

"This study was supported partly by National Natural Science Foundation of China (81400381) and Zhejiang Medical and Health Science and Technology Project (2018269795)."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"The authors received no specific funding for this work."

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear authors,

I would like to congratulate the authors for their efforts in studying a topic that is so relevant. I would like to bring to their attention the following:

1. Sampling: The authors have mentioned that participants were randomly sampled. This has the potential to introduce bias, hence It would be beneficial to the readers if this was explained further.

2. Validation: Was the questionnaire validated? The questionnaire could be attached as a supplementary file.

3. Table 4: It is not clear what the authors are trying to depict in this table. The column “All” probably needs to be deleted.

4. One of the components of the knowledge score is “DM can cause blindness”. This should not be compared with “concern about vision loss” as both mean the same.

5. The same comment goes for “regular eye exams are necessary” which is a component of knowledge score, should not be compared with “told regular examinations should be done”

6. Strength of association: Although the authors comment on the significant association between knowledge score and various factors, there is however no comment on the strength of association. There appears to be only a week association between most of the factors except college education.

“concern about vision loss” and “told regular examinations should be done” also have a higher strength of association for obvious reasons as they are part of the knowledge score. These should not be compared.

Reviewer #2: Dear colleague. I enjoyed reading the manuscript. I have a few suggestions enclosed with the PDF as comments. I have a concern regarding use of the term "Knowledge and attitudes", when really, after reading the paper, i get a sense that knowledge, practices, risk factors for poor knowledge and lack of screening, and sources of information have been inquired. Also, I suggest adding an explanation about how variables were selected for the multiple linear regression.

Reviewer #3: The authors have used a questionnaire based approach to gather the information. They sought to find out the knowledge and attitudes of diabetic patients to the aspects of diabetic retinopathy. The authors have not scientifically adequately addressed the research question of attitudes. The study has not accounted for some confounding variables such as source of the information and access to information if formal or informal and if any person known to the patient or the person himself/herself already had retinopathy. The study does not add any scientifically sound useful information.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Dr. Vivek Gupta

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: PONE-D-19-29504_reviewer VG.pdf
Revision 1

Dear Editors and Reviewers:

Thank you for your valuable suggestions and comments concerning our manuscript entitled “Knowledge and practices regarding diabetic retinopathy among diabetic patients registered in a chronic disease management system in eastern China”. Those comments are all extremely helpful for revising and improving our paper. We have carefully made necessary corrections accordingly, and highlighted in the paper.

Review Comments to the Author



Reviewer #1:

Dear authors,
I would like to congratulate the authors for their efforts in studying a topic that is so relevant. I would like to bring to their attention the following:

1. Sampling: The authors have mentioned that participants were randomly sampled. This has the potential to introduce bias, hence It would be beneficial to the readers if this was explained further.

Response: Thanks for your suggestion. We totally agree that we need to maximize the validity of inferences from what was observed in the study sample to what is happening in the population. The participants in our study were selected by simple random sampling method. We had edited in our manuscript.


2. Validation: Was the questionnaire validated? The questionnaire could be attached as a supplementary file.

Response: Thanks for asking this question. We actually did not validate that questionnaire since it has been used/validated in a previous published study from our institution (Ophthalmology.2010; 117:1755-62) with very few modifications.


3. Table 4: It is not clear what the authors are trying to depict in this table. The column “All” probably needs to be deleted.

Response: Thanks for your suggestion. We tried to display the responses of the participants to 7 different questions of DR knowledge. And we had deleted the column “All” in table 4 accordingly.


4. One of the components of the knowledge score is “DM can cause blindness”. This should not be compared with “concern about vision loss” as both mean the same.

Response: Thanks for your comments. We were trying to answering this similar question from two different approaches here, the score of “DM can cause blindness” was hoping to understand more from knowledge level, “concern about vision loss” was hoping to understand it from psychological level, so that we can see whether knowledge or psychological effects will interact on the same question or not.


5. The same comment goes for “regular eye exams are necessary” which is a component of knowledge score, should not be compared with “told regular examinations should be done”

Response: Similar like comments No.4, we were trying to answering the same question from different approaches. “regular eye exams are necessary” was hoping to understand it from knowledge level, “told regular examinations should be done” was hoping to find out whether this knowledge had been given by health care professionals, since even it had been told, but people may still say we didn’t feel it is necessary. We just tried to understand it in details.


6. Strength of association: Although the authors comment on the significant association between knowledge score and various factors, there is however no comment on the strength of association. There appears to be only a week association between most of the factors except college education.

Response: Thanks for your great suggestion. We had added it in the results section.


“concern about vision loss” and “told regular examinations should be done” also have a higher strength of association for obvious reasons as they are part of the knowledge score. These should not be compared.

Response: Please refer to our responses for comments No.4 and 5.



Reviewer #2:

Dear colleague. I enjoyed reading the manuscript. I have a few suggestions enclosed with the PDF as comments. I have a concern regarding use of the term "Knowledge and attitudes", when really, after reading the paper, i get a sense that knowledge, practices, risk factors for poor knowledge and lack of screening, and sources of information have been inquired. Also, I suggest adding an explanation about how variables were selected for the multiple linear regression.

Response: Thanks for your kind words and encouragement. We had edited our manuscript according to your suggestions. We had changed the word “attitudes” to “practice” in the title. And we had added an explanation about how variables were selected for the multiple linear regression. For most of comments you made in PDF, we have revised it directly in the manuscript with highlights.

I suggest that the authors avoid making a direct comparison with pre-CBPHS results of another region's population.

Response: Thanks for this valuable comments. We agree that a direct comparison may not be that appropriate, we have modified it accordingly.


Reviewer #3:

The authors have used a questionnaire based approach to gather the information. They sought to find out the knowledge and attitudes of diabetic patients to the aspects of diabetic retinopathy. The authors have not scientifically adequately addressed the research question of attitudes. The study has not accounted for some confounding variables such as source of the information and access to information if formal or informal and if any person known to the patient or the person himself/herself already had retinopathy. The study does not add any scientifically sound useful information.

Response: Thanks for taking the time and efforts to review our manuscript, we appreciate your constructive comments and agree that we need to continue to improve the quality of this manuscript. Here are our responses to the comments:

We agree that the term “attitude” was not appropriate to use, it was the “knowledge” of those participants being studied mostly in the manuscript. Therefore the term of “practice” is now being used to replace “attitude”.

Authors couldn’t agree anymore on the comments of potential confounding variables, those were indeed important factors we needed to address in this type of the observational study. The participants in our study were selected by simple random sampling method. Questionnaires were administered by a trained community physician, to help the participants fully understand the questions being asked. We have put some of potential confounding variables as the limitations in our manuscript (such as the source of the DM/DR information, the accessibility of the DM/DR information).

A few studies have been done to investigate the knowledge of DM/DR in general population in China, including a team from our institution, however, none was implemented after the established of chronic disease management system in 2009. The system was intended to manage patients and prevent complication, the aim of our paper was to access the current system’s influence on DM/DR knowledge fronts, and we hope our results can provide some new evidence on how to improve that chronic disease system. And we believe the cause of problem of DM/DR knowledge is quite universal.

Again, we appreciate all of your insightful comments. Thank you for taking the time to help us improve the paper, really appreciated!

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Wen-Jun Tu, Editor

Knowledge and practices regarding diabetic retinopathy among diabetic patients registered in a chronic disease management system in eastern China

PONE-D-19-29504R1

Dear Dr. Chen,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Wen-Jun Tu

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: No

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Thank You for addressing the concerns with the initial submission, that were raised in the first review.

Reviewer #3: The manuscript is better now. The authors have revised the paper keeping in view the reviewer comments.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Dr Vivek Gupta

Reviewer #3: No

Formally Accepted
Acceptance Letter - Wen-Jun Tu, Editor

PONE-D-19-29504R1

Knowledge and practices regarding diabetic retinopathy among diabetic patients registered in a chronic disease management system in eastern China

Dear Dr. Chen:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Wen-Jun Tu

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .